All Oncology articles

Journal

Can the Japanese phase I study be waived?

2024-03-06T15:00:00Z

New guidance: ‘Basic principles for conducting phase I studies in Japanese prior to initiating multi-regional clinical trials including Japan for drugs in which early clinical development is preceding outside Japan,’ issued in December 2023  

Journal

Overview of digital transformation in healthcare and initiatives in Japan

2024-03-06T15:00:00Z

 

Journal

Regulatory imperatives in chemistry, manufacturing, and control for biosimilars a comprehensive analysis

2024-03-06T15:00:00Z

 

Journal

Navigating the regulatory terrain down under: trends in Australia for 2024

2024-03-06T15:00:00Z

Regulatory Rapporteur March 2024 | Volume 21 | No.3 Introduction Australia is the most populous country in Oceania, and ranks 55th globally with its population around 26 million. It also ranks consistently high in other indicators that demonstrate the ...